Yahoo Web Search

Search results

1. • 

     Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease...

     Benzinga via Yahoo Finance· 8 hours ago

     On Thursday, Cerevel Therapeutics Holdings Inc. (NASDAQ:CERE) released topline results from its...

2. • 

     What's Going On AbbVie Stock On Friday?

     Benzinga via Yahoo Finance· 6 days ago

     Friday, AbbVie Inc (NYSE:ABBV) released an interim analysis of an ongoing Phase 3, open-label 156-week extension study evaluating the long-term safety...

3. • 

     15 Best Monthly Dividend Stocks To Buy Right Now

     Insider Monkey via Yahoo Finance· 3 days ago

     In this article, we discuss 15 best monthly dividend stocks to buy right now. You can skip our detailed analysis of dividend stocks and their previous...

4. • 

     What's Going On AbbVie Stock On Friday? - AbbVie (NYSE:ABBV)

     Benzinga· 6 days ago

     AbbVie releases interim analysis on atogepant, an oral migraine prevention drug. Key findings show...

5. • 

     12 Best Dividend Stocks with High Upside Potential

     Insider Monkey via Yahoo Finance· 3 days ago

     In this article, we discuss 12 best dividend stocks with high upside potential. You can skip our detailed analysis of dividend stocks and their past...

6. • 

     1 Simple Vanguard ETF Could Turn $500 Per Month Into $50,000 in Annual Dividend Income

     Motley Fool via Yahoo Finance· 5 days ago

     But they do, for the most part, offer yields above the S&P 500's average dividend yield of 1.31%....

7. • 

     US FDA warns of harmful reactions to fake Botox injections

     Reuters· 3 days ago

     , opens new tab Botox were given to consumers for cosmetic purposes in multiple states. The U.S....

8. • Abbvie Inc Insider Trading: What Did We Learn? – Stocks Register

     Stocks Register· 3 days ago

     Abbvie Inc (NYSE:ABBV) price is hovering higher on Tuesday, April 16, jumping 1.21% above its previous close. A look at today’s price movement shows that the recent level ...

9. • Smart Money Is Betting Big In ABBV Options - AbbVie (NYSE:ABBV)

     Benzinga· 7 days ago

     Loading... Loading... Deep-pocketed investors have adopted a bearish approach towards AbbVie ABBV , and it's something market players shouldn't ignore. Our tracking of public ...

10. • Medincell, AbbVie to Co-Develop Injectable Therapeutics

      Morningstar· 2 days ago

      Medincell and AbbVie plan to co-develop and commercialize as many as six injectable therapies under a collaboration deal worth up to nearly $2 billion. Medincell can rake ...